193 related articles for article (PubMed ID: 27644130)
21. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.
Katayama T; Imaizumi K; Sato N; Miyoshi K; Kudo T; Hitomi J; Morihara T; Yoneda T; Gomi F; Mori Y; Nakano Y; Takeda J; Tsuda T; Itoyama Y; Murayama O; Takashima A; St George-Hyslop P; Takeda M; Tohyama M
Nat Cell Biol; 1999 Dec; 1(8):479-85. PubMed ID: 10587643
[TBL] [Abstract][Full Text] [Related]
22. Analysis of calcium homeostasis in fresh lymphocytes from patients with sporadic Alzheimer's disease or mild cognitive impairment.
Jaworska A; Dzbek J; Styczynska M; Kuznicki J
Biochim Biophys Acta; 2013 Jul; 1833(7):1692-9. PubMed ID: 23354174
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.
Sato N; Urano F; Yoon Leem J; Kim SH; Li M; Donoviel D; Bernstein A; Lee AS; Ron D; Veselits ML; Sisodia SS; Thinakaran G
Nat Cell Biol; 2000 Dec; 2(12):863-70. PubMed ID: 11146649
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.
Eckert A; Schindowski K; Leutner S; Luckhaus C; Touchet N; Czech C; Müller WE
Neurobiol Dis; 2001 Apr; 8(2):331-42. PubMed ID: 11300728
[TBL] [Abstract][Full Text] [Related]
25. Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease.
Fukutani Y; Cairns NJ; Rossor MN; Lantos PL
Neurosci Lett; 1996 Aug; 214(1):33-6. PubMed ID: 8873125
[TBL] [Abstract][Full Text] [Related]
26. Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
Ma L; Ohyagi Y; Miyoshi K; Sakae N; Motomura K; Taniwaki T; Furuya H; Takeda K; Tabira T; Kira J
J Alzheimers Dis; 2009; 16(3):565-75. PubMed ID: 19276551
[TBL] [Abstract][Full Text] [Related]
27. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
[TBL] [Abstract][Full Text] [Related]
28. Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation.
Fukutani Y; Cairns NJ; Rossor MN; Lantos PL
J Neurol Sci; 1997 Aug; 149(2):177-84. PubMed ID: 9171327
[TBL] [Abstract][Full Text] [Related]
29. Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations.
Das HK; Tchedre K; Mueller B
J Neurochem; 2012 Aug; 122(3):487-500. PubMed ID: 22607268
[TBL] [Abstract][Full Text] [Related]
30. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.
Lazarov O; Morfini GA; Pigino G; Gadadhar A; Chen X; Robinson J; Ho H; Brady ST; Sisodia SS
J Neurosci; 2007 Jun; 27(26):7011-20. PubMed ID: 17596450
[TBL] [Abstract][Full Text] [Related]
31. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.
Levey AI; Heilman CJ; Lah JJ; Nash NR; Rees HD; Wakai M; Mirra SS; Rye DB; Nochlin D; Bird TD; Mufson EJ
Ann Neurol; 1997 Jun; 41(6):742-53. PubMed ID: 9189035
[TBL] [Abstract][Full Text] [Related]
32. Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.
Bellucci C; Lilli C; Baroni T; Parnetti L; Sorbi S; Emiliani C; Lumare E; Calabresi P; Balloni S; Bodo M
Mol Med; 2007; 13(9-10):542-50. PubMed ID: 17660861
[TBL] [Abstract][Full Text] [Related]
33. The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex.
Bogdanovic N; Zilmer M; Zilmer K; Rehema A; Karelson E
Dement Geriatr Cogn Disord; 2001; 12(6):364-70. PubMed ID: 11598307
[TBL] [Abstract][Full Text] [Related]
34. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
35. Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.
Esposito L; Gan L; Yu GQ; Essrich C; Mucke L
J Neurochem; 2004 Dec; 91(6):1260-74. PubMed ID: 15584903
[TBL] [Abstract][Full Text] [Related]
36. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
37. Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2.
Wang HQ; Nakaya Y; Du Z; Yamane T; Shirane M; Kudo T; Takeda M; Takebayashi K; Noda Y; Nakayama KI; Nishimura M
Hum Mol Genet; 2005 Jul; 14(13):1889-902. PubMed ID: 15905180
[TBL] [Abstract][Full Text] [Related]
38. Akt activity in presenilin 1 wild-type and mutation transfected human SH-SY5Y neuroblastoma cells after serum deprivation and high glucose stress.
Vestling M; Wiehager B; Tanii H; Cowburn RF
J Neurosci Res; 2001 Nov; 66(3):448-56. PubMed ID: 11746362
[TBL] [Abstract][Full Text] [Related]
39. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
[TBL] [Abstract][Full Text] [Related]
40. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
